MedPath

Herb Drug Interaction of Traditional Chinese Herb and Commonly Used Drugs

Phase 1
Conditions
Healthy
Interventions
Registration Number
NCT00923000
Lead Sponsor
Tri-Service General Hospital
Brief Summary

The purpose of this study was to investigate a possible response to nalbuphine (Nubian) and morphine with traditional Chinese herbs in healthy volunteers.

Detailed Description

This study is a single center and open-label design to investigate the pharmacokinetic properties of Nubian, Nubian traditional Chinese herb combination dosage after single oral with oral administration, or morphine, morphine traditional Chinese herb combination dosage after single oral administration in healthy volunteers under fasting conditions.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
50
Inclusion Criteria
  • Normal healthy adult subjects between 20-40 years of age
  • Body weight within 80-120% of ideal body weight
  • Acceptable medical history, physical examination and clinical laboratory determinations
Exclusion Criteria
  • Recent history of drug or alcohol addiction or abuse
  • Donating greater than 150 ml of blood within two months prior to Period I
  • Taking any prescription medication or any nonprescription medication within 14 days prior to Period I doing
  • Receiving any investigational drug within 30 days prior to Period I dosing
  • Taking any drug known to induce or inhibit hepatic drug metabolism within 30 days prior to the beginning of the study
  • Any clinically significant diseases
  • History of allergic response to nalbuphine or related drugs and traditional Chinese herbs

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Nubian with Long dan xie gan tang 3gNubian with Long dan xie gan tang-
MorphineMorphine-
Morphine with Long dan xie gan tangMorphine with Long dan xie gan tang-
Nubian with Long dan xie gan tang 3g tidNalbuphine with Long dan xie gan tang-
NalbuphineNalbuphine-
Primary Outcome Measures
NameTimeMethod
The pharmacokinetic parameters24 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tri-Service General Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath